首页 | 本学科首页   官方微博 | 高级检索  
检索        

2006—2008年我院口服降糖药物的应用分析
引用本文:伦新强.2006—2008年我院口服降糖药物的应用分析[J].中国药物应用与监测,2009,6(5):288-291.
作者姓名:伦新强
作者单位:柳州医学高等专科学校第一附属医院,柳州,545002
摘    要:目的:分析我院口服降糖药物的使用情况及趋势。方法:以销售金额、用药频度、日均费用、排序比等为指标,对我院2006—2008年口服降糖药物使用情况进行统计分析。结果:38.3年来我院在口服降血糖药品使用上有些波动,总体应用上基本合理。我院主要使用的品种有阿卡波糖、罗格列酮、格列喹酮、格列美脲和二甲双胍等,临床应注意考虑降低费用和加强合理用药监测。结论:经济、合理的选用口服降糖药,有助于控制血糖和提高患者的生活质量。

关 键 词:口服降糖药物  销售金额  限定日剂量

Analysis of Utilization of Oral Hypoglycemic Drugs in Our Hospital from 2006 to 2008
Authors:LUN Xin-qiang
Institution:LUN Xin-qiang(The First Hospital Affiliated to Liuzhou Medical College, Liuzhou, 545002)
Abstract:Objective: To analyze the use of oral hypoglycemic drugs in our hospital and provide reference for rational drug use in clinic. Methods: We analyzed the use of oral hypoglycemic drugs based on consumption sum and order, DDDs, DDC and order ratio in our hospital from 2006 to 2008. Results: Utilization of oral hypoglycemic agents in our hospital was basically rational. Consumption sum and DDDs were fluctuant. The top 5 of hypoglycemic drugs in terms of both sales amount and DDDs were acarbose, rosiglitazone, gliquidone, glimepiride and dimethyldiguanide. The decreasing of medical cost and the monitoring of rational use of oral hypoglycemics should be paid more attention. Conclusion: The effective control of blood glucose and improvement in quality of life in the diabetic patients will benefit from economical and rational use of oral hypoglycemic drugs.
Keywords:Oral hypoglycemic drug  Sales amount  Defined daily dose
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号